Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis?

被引：11
作者：
Dantas, Ana Paula V. [1 ]
Sandberg, Kathryn [1 ]
机构：
[1] Georgetown Univ, Ctr Study Sex Differences Hlth Aging & Dis, Washington, DC 20057 USA
来源：
CIRCULATION RESEARCH | 2006年 / 99卷 / 03期
关键词：
D O I：
10.1161/01.RES.0000236802.00855.cd
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：234 / 237
页数：4
相关论文
共 30 条
[1]   Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs [J].
Barchiesi, F ;
Jackson, EK ;
Gillespie, DG ;
Zacharia, LC ;
Fingerle, J ;
Dubey, RK .
HYPERTENSION, 2002, 39 (04) :874-879
[2]   2-methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle [J].
Barchiesi, Federica ;
Jackson, Edwin K. ;
Fingerle, Juergen ;
Gillespie, Delbert G. ;
Odermatt, Bernhard ;
Dubey, Raghvendra K. .
CIRCULATION RESEARCH, 2006, 99 (03) :266-274
[3]   Bi-directional actions of estrogen on the renin-angiotensin system [J].
Brosnihan, KB ;
Senanayake, PS ;
Li, P ;
Ferrario, CM .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (04) :373-381
[4]   Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [J].
Brunner, H ;
Cockcroft, JR ;
Deanfield, J ;
Donald, A ;
Ferrannini, E ;
Halcox, J ;
Kiowski, W ;
Luscher, TF ;
Mancia, G ;
Natali, A ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Spieker, LE ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (02) :233-246
[5]   Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome [J].
Christian, RC ;
Dumesic, DA ;
Behrenbeck, T ;
Oberg, AL ;
Sheedy, PF ;
Fitzpatrick, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2562-2568
[6]   Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women [J].
Christian, RC ;
Harrington, S ;
Edwards, WD ;
Oberg, AL ;
Fitzpatrick, LA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1062-1067
[7]   Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms [J].
Dubey, RK ;
Jackson, EK .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (03) :F365-F388
[8]   Cardiovascular pharmacology of estradiol metabolites [J].
Dubey, RK ;
Tofovic, SP ;
Jackson, EK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :403-409
[9]   Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism [J].
Dubey, RK ;
Jackson, EK ;
Keller, PJ ;
Imthurn, B ;
Rosselli, M .
HYPERTENSION, 2001, 37 (02) :640-644
[10]   Loss of atheroprotective effect of estradiol in immunodeficient mice. [J].
Elhage, R ;
Clamens, S ;
Reardon-Alulis, C ;
Getz, GS ;
Fievet, C ;
Maret, A ;
Arnal, JF ;
Bayard, F .
ENDOCRINOLOGY, 2000, 141 (01) :462-465
123